The close ties of iron to the pathological proteins (Robinson et al., 2018), Aβ, tau, α-synuclein and TDP43, means that successful therapeutic targets involving iron biology would be translatable to several neurodegenerative diseases. This evidence concerns the gene TARDBP and neurodegenerative disease.